ABSTRACT Churg-Strauss syndrome (CSS), or allergic granulomatosis, is a rare disease manifested by tissue infiltration, hypereosinophilia and vasculitis. Renal involvement may be seen in up to 50% of cases. We report the case of a 25-yearold man who presented with a history of fever for two months, tingling, numbness, and paraesthesia of the upper limbs and left lower limb, along with diarrhoea for one month and an inability to walk for the past seven days. Serial laboratory investigations helped to reach the final diagnosis of CSS with mononeuritis multiplex, and skin, pulmonary and gastrointestinal involvement with hypertension. This is due to renal involvement in the form of focal segmental glomerulosclerosis without any nephrotic range proteinuria, which is a very rare clinical entity. The patient's symptoms were relieved after the administration of an unconventional mode of therapy.
INTRODUCTION
Churg-Strauss syndrome (CSS) should be considered when there is late onset of asthma, worsening asthma or a rash, along with either numbness or pain in the extremities, a lingering cough, sinus problems, stomach problems, or symptoms suggestive of cardiac involvement. In an autopsy series, the kidney is affected in over 50% of cases and clinical renal involvement has been described in 25% to more than 90% of cases.
(1) In a review study, only 21
cases of CSS were identified among almost 185,000 asthmatic patients who were on medication. (1) Features of renal biopsies of CSS vary widely from normal kidney tissue to vasculitis, severe glomerulonephritis and interstitial inflammation. (2) Crescentic glomerulonephritis and focal necrotising glomerulonephritis are the most commonly encountered renal lesions in CSS, affecting men slightly more than women. It can affect people of all ages, with the average age at diagnosis ranging from 35-45 years. Human eosinophil cationic proteins, which are capable of tissue destruction in a variety of hypereosinophilic syndromes, have been found in granulomatous tissue in patients with CSS. (3, 4) Although therapeutic trials in CSS are limited, they have shown that glucocorticoid alone and glucocorticoid combined with cyclophosphamide are both effective.
CASE REPORTS
A 25-year-old man presented with a history of fever for the past two months. The patient complained of tingling, numbness and paraesthesia of both the upper limbs and the left lower limb over a period of one month, and an inability to walk for the past seven days. This was associated with persistent diarrhoea for the past one month. He was diagnosed with bronchial asthma and allergic rhinitis two years ago. His peripheral blood smear then had shown a high eosinophil count and spirometry had been consistent with moderate obstruction with significant reactivity.
He was discharged with a prescription of an inhaler and a short course of oral steroids. After 18 months of being symptom-free, he again developed a minimally productive cough with an evening rise of low-grade temperature without chills or rigor. Sputum for an acid fast bacilli smear report was negative and the chest radiograph revealed diffuse, multiple, nonspecific nodular infiltrates ( 
DISCUS SION
Churg and Strauss first described CSS in 1951. In their original article, they described three pathological features of the disease -eosinophilic tissue infiltration, granuloma formation and necrotising vasculitis that primarily involves small-and mediumsized vessels. (6) Asthma, one of the important features of CSS, may appear a long time before the clinical appearance of vasculitis.
Our patient had developed gastrointestinal vasculitis, probably in the form of diarrhoea, and mononeuritis multiplex in the form of tingling, numbness, wrist drop and wasting of the small muscles of the hand. These mild glomerular changes are described as affecting only a small number of glomeruli. (4) However, in the Hammersmith series of 13 renal biopsy specimens, 11 showed focal glomerulonephritis, with necrotising features present in eight and crescents in nine. (7) By IF, areas of necrosis in the glomeruli may contain IgM, C3 and fibrinogen. (2, 7, 8) One report revealed immunoglobulin A staining in the glomerulus. (3, 6) Both peripheral blood and tissue eosinophilia are major manifestations of the syndrome, and the majority of patients tested have increased IgE levels. (9) The ACR criteria we used to make a diagnosis of from the onset is that the initial clinical presentation would be rapidly progressive glomerulonephritis, which was not the case in our patient. (10) It is unfortunate that CSS in the early stages is often underdiagnosed. If detected early, CSS would be more responsive to corticosteroid therapy, while cases with advanced vasculitis may require the addition of more powerful immunosuppressive drugs. (11) Our patient was put on intravenous methylprednisolone, followed by oral steroids. He was initially prescribed oral cyclophosphamide, as per conventional textbook guidelines of the management of CSS. However, the patient did not receive any clinical or biochemical benefit, and we decided to switch his treatment to intravenous cyclophosphamide. This showed excellent results with considerable disability limitation and a significant drop in eosinophil count. He continued taking oral steroids and cyclophosphamide, and his fever and diarrhoea had subsided. He was put on a cock-up splint for his wrist drop and was doing well at the time of this writing.
As CSS is not curable and relapses or flares are common, it is very important that the disease is carefully monitored by a physician throughout its course, with regularly scheduled laboratory tests even when in remission. (3) CSS is a chronic and sometimes life-threatening disease, but with effective medical care, most patients can have a good quality of life. In a study by Sinico et al, (12) 11 out of 16 cases of CSS that underwent kidney biopsy showed features of necrotising crescentic glomerulonephritis, of which all were p-ANCA positive.
In summary, we have reported a rare case of CSS with an uncommon renal involvement, which was treated unconventionally. In this case, renal involvement was not in the form of rapidly progressive glomerulonephritis but focal segmental glomerulosclerosis, which is an uncommon clinical correlation in this disease scenario. Apart from that, the patient's renal vasculitis did not manifest with nephritic or nephritic range proteinuria, which is again a rarity, and his nephritis responded to an unconventional mode of therapy.
